To begin understanding the impact of the chronic presence of P. aeruginosa on the levels of C5a in the lung, we first determined the production of C5a through the activation of complement’s terminal pathway by three pairs of clonally related isolates, including the earliest (early) and the latest (late) available isolates recovered from three chronically infected CF patients. This evidence concerns the gene C5AR1 and cystic fibrosis.